Table 1.
Baseline characteristics of patients in cabergoline-treated and control groups
| Baseline characteristics |
Cabergoline
n=50 |
Control
n=25 |
P value |
|---|---|---|---|
| Age (year) | 28.24±4.93 | 28.80±4.63 | 0.637 |
| BMI (kg/m2) | 24.86±6.83 | 24.08±3.65 | 0.596 |
| Type of infertility | |||
| Primary | 38 (76%) | 19 (76%) | 1 |
| Secondary | 12 (24%) | 6 (24%) | 1 |
| Cause of infertility | |||
| Male factors | 27 (54%) | 8 (32%) | 0.062 |
| Female factors | 8 (16%) | 11 (44%) | 0.055 |
| Male and female factors | 10 (20%) | 5 (20%) | 0.058 |
| Unexplained factors | 5 (10%) | 1(4%) | |
| PCOS | 25 (50.0%) | 15 (60.0%) | 0.413 |
| History of OHSS | 2 (4.0%) | 1 (4.0%) | 1 |
| FSH (IU/L) | 5.88±1.5 | 5.54±1.6 | 0.90 |
| LH (IU/L) | 7.28±2.1 | 5.21±1.9 | 0.78 |
Values are presented as mean±SD or frequency (percent). BMI; body mass index, PCOS; polycystic ovarian syndrome, OHSS; ovarian hyperstimulation syndrome, FSH; follicle stimulation hormone, LH; leutinizing hormone